EODData

MEMBERSHIP REGISTER LOG IN

FRA, 1FW1: WUXI BIOLOGICS UNSP.ADR/2

22 Dec 2025
LAST:

7.000

CHANGE:
 0.30		OPEN:
7.000		HIGH:
7.000		ASK:
0.000		VOLUME:
3
CHG(%):
4.11		PREV:
7.300		LOW:
7.000		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
22 Dec 257.0007.0007.0007.0003
19 Dec 257.3007.3007.3007.3003
18 Dec 256.9506.9506.9506.9503
17 Dec 257.1007.2007.1007.2003
16 Dec 256.8007.1506.8007.150105
15 Dec 256.9006.9006.9006.900823
12 Dec 257.1007.1007.1007.100823
10 Dec 257.2507.2507.2507.250823
09 Dec 257.2507.2507.2507.250823
08 Dec 257.2007.2007.2007.200823

PROFILE

Name:WUXI BIOLOGICS UNSP.ADR/2
About:WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People's Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing organization platforms, including WuXiBody, SDArBodY, T cell engager, Single B Cell Cloning Technology, WuXia, WuXiUP, WuXiUI, and WuXiHigh. It engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, production and sales of medicals, and biologics clinical and manufacturing services; production and sale of medicals; vaccine contract development and manufacturing organization (CDMO) and related business; and engages in investment and material supplier activities. It has a research service agreement with BioNTech SE to discover and investigate monoclonal antibodies for developing next-generation therapeutic product candidates. The company was incorporated in 2014 and is headquartered in Wuxi, China.
Sector:Healthcare
Industry:Biotechnology
Address:No. 108, Meiliang Road, Wuxi, China, 214092
Website:https://www.wuxibiologics.com
ISIN:US98260N1081
LEI:5493001TD2TH6VDTJU11

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:32.29 
Forward P/E:26.67 
Price to Sales:0.80 
Price to Book:0.70 
Profit Margin:0.21 
Operating Margin:0.27 
Return on Assets:0.06 
Return on Equity:0.11 
Revenue:2.444B 
EBITDA:803.21M 
Shares:2.023B 
Market Cap:14.161B 

TECHNICAL INDICATORS

MA5:7.121.7%
MA10:7.131.9%
MA20:7.030.5%
MA50:7.466.6%
MA100:7.486.9%
MA200:6.488.0%
STO9:25.00
STO14:50.00
RSI14:51.06
WPR14:-50.00
MTM14:0.15
ROC14:0.02 
ATR:0.18 
Week High:7.304.3%
Week Low:6.802.9%
Month High:7.304.3%
Month Low:6.708.0%
Year High:9.2031.4%
Year Low:3.9179.0%
Volatility:38.61